Kathleen Young Roby,
Troy Skaggs www.ncbi.nlm.nih.gov
Troy Skaggs www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
Role of Cannabinoids in the Development of Fatty Liver (Steatosis) www.ncbi.nlm.nih.gov Emerging evidence suggests that…
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844512/ www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
Role of Cannabinoids in the Development of Fatty Liver
How can they continue to keep cannabis as schedule 1, when THERE OWN STUDIES continually document medical application and value?